v2+ Vocabulary
0.3.0 - Working Draft to present the concept ideas (FO)
v2+ Vocabulary - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://terminology.hl7.org/v2plusvocab/ValueSet/hl7VSvaccinesAdministeredV110 | Version: 1.1.0 | |||
| Active as of 2025-08-05 | Computable Name: Hl7VSvaccinesAdministeredV110 | |||
| Other Identifiers: OID:2.16.840.1.113883.21.194 | ||||
Copyright/Legal: HL7 Inc., 2024 |
||||
HL7-published value Set of codes that specify the administered vaccines. Superceded by 2.16.840.1.114222.4.11.934, published by the US Centers for Disease Control and Prevention (CDC).
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110
Expansion performed internally based on codesystem Vaccines Administered (2.3.1 - 1.1.0) v1.1.0 (CodeSystem)
This value set contains 92 concepts
| Code | System | Display (en-US) | Definition |
| 01 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | DTP | DTP |
| 02 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | OPV | OPV |
| 03 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | MMR | MMR |
| 04 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | M/R | M/R |
| 05 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Measles | Measles |
| 06 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rubella | Rubella |
| 07 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Mumps | Mumps |
| 08 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep B, adolescent or pediatric | Hep B, adolescent or pediatric |
| 09 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Td (Adult) | Td (Adult) |
| 10 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | IPV | IPV |
| 11 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Pertussis | Pertussis |
| 12 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Diphtheria antitoxin | Diphtheria antitoxin |
| 13 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | TIG | TIG |
| 14 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | IG, NOS | IG, NOS |
| 15 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Influenza—split (incl. purified surface antigen) | Influenza—split (incl. purified surface antigen) |
| 16 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Influenza—whole | Influenza—whole |
| 17 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hib, NOS | Hib, NOS |
| 18 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rabies, intramuscular injection | Rabies, intramuscular injection |
| 19 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | BCG | BCG |
| 20 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | DTaP | DTaP |
| 21 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Varicella | Varicella |
| 22 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | DTP-Hib | DTP-Hib |
| 23 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Plague | Plague |
| 24 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Anthrax | Anthrax |
| 25 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Typhoid—oral | Typhoid—oral |
| 26 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Cholera | Cholera |
| 27 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Botulinum antitoxin | Botulinum antitoxin |
| 28 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | DT(pediatric) | DT(pediatric) |
| 29 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | CMVIG | CMVIG |
| 30 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | HBIG | HBIG |
| 31 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep A, pediatric, NOS | Hep A, pediatric, NOS |
| 32 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Meningococcal | Meningococcal |
| 33 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Pneumococcal | Pneumococcal |
| 34 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | RIG | RIG |
| 35 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Tetanus toxoid | Tetanus toxoid |
| 36 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | VZIG | VZIG |
| 37 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Yellow fever | Yellow fever |
| 38 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rubella/Mumps | Rubella/Mumps |
| 39 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Japanese encephalitis | Japanese encephalitis |
| 40 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rabies, intradermal injection | Rabies, intradermal injection |
| 41 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Typhoid-parenteral | Typhoid-parenteral |
| 42 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep B, adolescent/high risk infant | Hep B, adolescent/high risk infant |
| 43 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep B, adult | Hep B, adult |
| 44 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep B, dialysis | Hep B, dialysis |
| 45 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep B, NOS | Hep B, NOS |
| 46 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hib (PRP-D) | Hib (PRP-D) |
| 47 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hib (HbOC) | Hib (HbOC) |
| 48 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hib (PRP-T) | Hib (PRP-T) |
| 49 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hib (PRP-OMP) | Hib (PRP-OMP) |
| 50 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | DtaP-Hib | DtaP-Hib |
| 51 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hib-Hep B | Hib-Hep B |
| 52 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep A - adult | Hep A - adult |
| 53 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Typhoid, parenteral, AKD (U.S. military) | Typhoid, parenteral, AKD (U.S. military) |
| 54 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Adenovirus, type 4 | Adenovirus, type 4 |
| 55 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Adenovirus, type 7 | Adenovirus, type 7 |
| 56 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Dengue fever | Dengue fever |
| 57 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hantavirus | Hantavirus |
| 58 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep C | Hep C |
| 59 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep E | Hep E |
| 60 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Herpes simplex 2 | Herpes simplex 2 |
| 61 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | HIV | HIV |
| 62 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | HPV | HPV |
| 63 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Junin virus | Junin virus |
| 64 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Leishmaniasis | Leishmaniasis |
| 65 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Leprosy | Leprosy |
| 66 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Lyme disease | Lyme disease |
| 67 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | malaria | malaria |
| 68 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Melanoma | Melanoma |
| 69 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Parainfluenza-3 | Parainfluenza-3 |
| 70 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Q fever | Q fever |
| 71 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | RSV-IGIV | RSV-IGIV |
| 72 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rheumatic fever | Rheumatic fever |
| 73 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rift Valley fever | Rift Valley fever |
| 74 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rotavirus | Rotavirus |
| 75 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Smallpox | Smallpox |
| 76 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Staphylococcus bacterio lysate | Staphylococcus bacterio lysate |
| 77 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Tick-borne encephalitis | Tick-borne encephalitis |
| 78 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Tularemia vaccine | Tularemia vaccine |
| 79 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Vaccinia immune globulin | Vaccinia immune globulin |
| 80 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | VEE, live | VEE, live |
| 81 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | VEE, inactivated | VEE, inactivated |
| 82 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Adenovirus, NOS | Adenovirus, NOS |
| 83 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep A, ped/adol, 2 dose | Hep A, ped/adol, 2 dose |
| 84 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep A, ped/adol, 3 dose | Hep A, ped/adol, 3 dose |
| 85 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Hep A, NOS | Hep A, NOS |
| 86 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | IG | IG |
| 87 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | IGIV | IGIV |
| 88 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Influenza, NOS | Influenza, NOS |
| 89 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | polio, NOS | Polio, NOS |
| 90 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | Rabies, NOS | Rabies, NOS |
| 91 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | typhoid, NOS | Typhoid, NOS |
| 92 | http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7V110 | VEE, NOS | VEE, NOS |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |